D.A. Davidson & Co. Gsk PLC Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$42.05 - $47.77 $1.24 Million - $1.41 Million	29,500 Added 19.24%	182,831 $7.96 Million
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $118,034 - $140,069	2,934 Added 1.95%	153,331 $6.68 Million
Q4 2021 Jan 31, 2022	SELL	$38.88 - $45.31 $76,788 - $89,487	-1,975 Reduced 1.3%	150,397 $6.63 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $715,597 - $796,215	-18,448 Reduced 10.8%	152,372 $5.82 Million
Q2 2021 Aug 10, 2021	SELL	$36.52 - $41.46 $1.88 Million - $2.13 Million	-51,449 Reduced 23.15%	170,820 $6.8 Million
Q1 2021 May 07, 2021	BUY	$34.27 - $40.01 $659,491 - $769,952	19,244 Added 9.48%	222,269 $7.93 Million
Q4 2020 Feb 10, 2021	SELL	$34.07 - $39.94 $648,624 - $760,377	-19,038 Reduced 8.57%	203,025 $7.48 Million
Q3 2020 Nov 02, 2020	SELL	$38.11 - $42.99 $196,533 - $221,699	-5,157 Reduced 2.27%	222,063 $8.36 Million
Q2 2020 Aug 10, 2020	SELL	$37.87 - $43.58 $1.31 Million - $1.51 Million	-34,566 Reduced 13.2%	227,220 $9.27 Million
Q1 2020 May 05, 2020	BUY	$32.47 - $48.83 $669,401 - $1.01 Million	20,616 Added 8.55%	261,786 $9.91 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $171,402 - $196,908	4,081 Added 1.72%	241,170 $11.3 Million
Q3 2019 Nov 05, 2019	SELL	$40.46 - $43.52 $28,928 - $31,116	-715 Reduced 0.3%	237,089 $10.1 Million
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $285,374 - $309,276	7,243 Added 3.14%	237,804 $9.52 Million
Q1 2019 May 13, 2019	BUY	$38.57 - $42.69 $447,219 - $494,990	11,595 Added 5.3%	230,561 $9.56 Million
Q4 2018 Jan 29, 2019	SELL	$37.8 - $42.69 $1.27 Million - $1.44 Million	-33,638 Reduced 13.32%	218,966 $8.37 Million
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $3.21 Million - $3.45 Million	80,777 Added 47.01%	252,604 $10.1 Million
Q2 2018 Aug 02, 2018	BUY	$39.61 - $42.76 $297,075 - $320,700	7,500 Added 4.56%	171,827 $6.93 Million
Q1 2018 May 04, 2018	BUY	$36.18 - $40.15 $350,186 - $388,611	9,679 Added 6.26%	164,327 $6.42 Million
Q4 2017 Feb 08, 2018	SELL	$35.34 - $41.9 $441,962 - $524,001	-12,506 Reduced 7.48%	154,648 $5.49 Million
Q3 2017 Nov 08, 2017	SELL	$39.44 - $41.55 $19,483 - $20,525	-494 Reduced 0.29%	167,154 $6.79 Million
Q2 2017 Aug 11, 2017	BUY	N/A	167,648	167,648 $0

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account